Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 123857
Published online Nov 15, 2026. doi: 10.4251/wjgo.123857
Published online Nov 15, 2026. doi: 10.4251/wjgo.123857
Table 1 Basic patient characteristics and short-term efficacy, n (%)
| Characteristic | Overall (n = 181) | FOLFOX (n = 68) | P-SOX (n = 113) | Statistic | P value1 |
| Age | χ2 = 0.02 | 0.894 | |||
| 0 | 100 (55.2) | 38 (55.9) | 62 (54.9) | ||
| 1 | 81 (44.8) | 30 (44.1) | 51 (45.1) | ||
| Sex | χ2 = 0.09 | 0.763 | |||
| 1 | 151 (83.4) | 56 (82.4) | 95 (84.1) | ||
| 2 | 30 (16.6) | 12 (17.6) | 18 (15.9) | ||
| cT | χ2 = 0.28 | 0.868 | |||
| 2 | 40 (22.1) | 16 (23.5) | 24 (21.2) | ||
| 3 | 92 (50.8) | 35 (51.5) | 57 (50.4) | ||
| 4 | 49 (27.1) | 17 (25.0) | 32 (28.3) | ||
| cN | χ2 = 0.05 | 0.825 | |||
| 0 | 55 (30.4) | 20 (29.4) | 35 (31.0) | ||
| 1 | 126 (69.6) | 48 (70.6) | 78 (69.0) | ||
| cTNM | χ2 = 2.00 | 0.572 | |||
| 1 | 87 (48.1) | 37 (54.4) | 50 (44.2) | ||
| 2 | 21 (11.6) | 6 (8.8) | 15 (13.3) | ||
| 3 | 33 (18.2) | 11 (16.2) | 22 (19.5) | ||
| 4 | 40 (22.1) | 14 (20.6) | 26 (23.0) | ||
| ASA | χ2 = 0.39 | 0.530 | |||
| 0 | 153 (84.5) | 56 (82.4) | 97 (85.8) | ||
| 1 | 28 (15.5) | 12 (17.6) | 16 (14.2) | ||
| Differentiation | χ2 = 0.28 | 0.871 | |||
| 1 | 50 (27.6) | 18 (26.5) | 32 (28.3) | ||
| 2 | 53 (29.3) | 19 (27.9) | 34 (30.1) | ||
| 3 | 78 (43.1) | 31 (45.6) | 47 (41.6) | ||
| RECIST 11 | χ2 = 1.60 | 0.206 | |||
| 0 | 77 (42.5) | 33 (48.5) | 44 (38.9) | ||
| 1 | 104 (57.5) | 35 (51.5) | 69 (61.1) | ||
| TRG | χ2 = 1.16 | 0.281 | |||
| 0 | 51 (28.2) | 16 (23.5) | 35 (31.0) | ||
| 1 | 130 (71.8) | 52 (76.5) | 78 (69.0) | ||
| Tumor diameter | χ2 = 4.57 | 0.102 | |||
| 1 | 73 (40.3) | 34 (50.0) | 39 (34.5) | ||
| 2 | 68 (37.6) | 20 (29.4) | 48 (42.5) | ||
| 3 | 40 (22.1) | 14 (20.6) | 26 (23.0) | ||
| Location | χ2 = 0.35 | 0.839 | |||
| 1 | 41 (22.7) | 14 (20.6) | 27 (23.9) | ||
| 2 | 73 (40.3) | 29 (42.6) | 44 (38.9) | ||
| 3 | 67 (37.0) | 25 (36.8) | 42 (37.2) |
- Citation: Ji BY, Qi LL, Fan DY, Zhang Y, He L, Zhang K, Liu ZB. Nab-paclitaxel-oxaliplatin-S-1 vs FOLFOX in locally advanced gastric cancer: Efficacy and postoperative disease-free survival prediction. World J Gastrointest Oncol 2026; 18(11): 123857
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/123857.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123857